Last reviewed · How we verify
NCT03772808
Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS)
NA trial testing Lycocomfort in BPH in 52 participants. Completed in 15 June 2019.
30 April 2019
Quick facts
| Lead sponsor | LycoRed Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 52 |
| Start date | 16 November 2018 |
| Primary completion | 30 April 2019 |
| Estimated completion | 15 June 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lycocomfort
Conditions studied
- BPH — all drugs for BPH →
- Lower Urinary Tract Symptoms — all drugs for Lower Urinary Tract Symptoms →
Sponsor
LycoRed Ltd.
Who can join
40 and older, male only, with BPH or Lower Urinary Tract Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will evaluate LycoComfort™ supplementation in alleviating symptoms associated with LUTS, BPH, and general prostate concerns. Inflammation, oxidative stress and androgenic activity in the prostate are proven catalysts of BPH, ultimately leading to increased prostate cell proliferation. The once-daily supplement LycoComfort™, will be under investigation for symptom relief and will be taken by participants for a duration of 12 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03772808
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for BPH
Currently open trials in the same condition.
- NCT07115147 — Blue Diode Laser Vaporization for BPH · NA · recruiting
- NCT05401032 — Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH. · Phase 2 · recruiting
- NCT05719220 — Effect of Group Preoperative Pelvic Floor Training for HoLEP · recruiting
- NCT05620784 — Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP · Phase 3 · recruiting
- NCT05330520 — Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Pat · NA · recruiting
Other LycoRed Ltd. trials
Trials by the same sponsor.
- NCT05376501 — A Study to Evaluate the Effect of Astaxanthin in Healthy Participants · NA · completed
- NCT05537350 — A Clinical Study to Evaluate the Efficacy and Consumer Perception of Lumenato · NA · completed
- NCT05328388 — A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants. · NA · completed
- NCT04356456 — A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Sk · NA · withdrawn
- NCT04248699 — Lumenato Nutritional Supplement on Skin Appearance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03772808 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LycoRed Ltd.
- Last refreshed: 2 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03772808.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing